AI assistant
Sending…
TG THERAPEUTICS, INC. — Director's Dealing 2021
Jan 4, 2021
31066_dirs_2021-01-04_a6f5560d-7044-4d9e-97b9-1905f760314b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2020-12-30
Reporting Person: Power Sean A (CFO, Secretary and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-30 | COMMON STOCK | A | 20000 | — | Acquired | 653338 | Direct |
Footnotes
F1: Reflects a grant of restricted shares relating to 2020 service and performance. This award will vest in approximately equal tranches on January 1, 2022, 2023, 2024 and 2025.
F2: Includes shares of restricted Common Stock, which are subject to vesting.
More from TG THERAPEUTICS, INC.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 13
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Nov 25